Ann: Appendix 4D and Half-year Report, page-4

I was just in the middle of copying and pasting the same thing, it's not a matter of "if" more a matter of "when" essentially.

"The Group has chosen a small number of potential final formulas and evaluating potential manufacture options for Presendin".

Doesn't seem like they will waste any time once the results are out, the formula is already chose by the sounds of it and they will just pull the trigger on the producer. I wouldn't be surprised if they already had the staff at the UB planning for the Registration Study.

Also interesting to note the "certain vesting conditions" surround the options that were issued, would love to know what the conditions are...maybe keeping the price at $x.xx amount for x amount of consecutive days.

We have held up quite well, again the Coronavirus has very little impact on the company so only nervous nellies would be selling.